{
    "q": [
        {
            "docid": "35746225_32",
            "document": "Cancer epigenetics . Cancers have high levels of genome instability, associated with a high frequency of mutations. A high frequency of genomic mutations increases the likelihood of particular mutations occurring that activate oncogenes and inactivate tumor suppressor genes, leading to carcinogenesis. On the basis of whole genome sequencing, cancers are found to have thousands to hundreds of thousands of mutations in their whole genomes. (Also see Mutation frequencies in cancers.) By comparison, the mutation frequency in the whole genome between generations for humans (parent to child) is about 70 new mutations per generation. In the protein coding regions of the genome, there are only about 0.35 mutations between parent/child generations (less than one mutated protein per generation). Whole genome sequencing in blood cells for a pair of identical twin 100-year-old centenarians only found 8 somatic differences, though somatic variation occurring in less than 20% of blood cells would be undetected.",
            "score": 164.89471006393433
        },
        {
            "docid": "3232713_4",
            "document": "Heritability of autism . Genetic linkage analysis has been inconclusive; many association analyses have had inadequate power. For each autistic individual, mutations in more than one gene may be implicated. Mutations in different sets of genes may be involved in different autistic individuals. There may be significant interactions among mutations in several genes, or between the environment and mutated genes. By identifying genetic markers inherited with autism in family studies, numerous candidate genes have been located, most of which encode proteins involved in neural development and function. However, for most of the candidate genes, the actual mutations that increase the risk for autism have not been identified. Typically, autism cannot be traced to a Mendelian (single-gene) mutation or to single chromosome abnormalities such as fragile X syndrome or 22q13 deletion syndrome. The large number of autistic individuals with unaffected family members may result from copy number variations (CNVs)\u2014spontaneous alterations in the genetic material during meiosis that delete or duplicate genetic material. Sporadic (non-inherited) cases have been examined to identify candidate genetic loci involved in autism. A substantial fraction of autism may be highly heritable but not inherited: that is, the mutation that causes the autism is not present in the parental genome.",
            "score": 191.12240707874298
        },
        {
            "docid": "52789_9",
            "document": "Androgen insensitivity syndrome . As of 2010, over 400 \"AR\" mutations have been reported in the \"AR\" mutation database, and the number continues to grow. Inheritance is typically maternal and follows an X-linked recessive pattern; individuals with a 46,XY karyotype always express the mutant gene since they have only one X chromosome, whereas 46,XX carriers are minimally affected. About 30% of the time, the \"AR\" mutation is a spontaneous result, and is not inherited. Such \"de novo\" mutations are the result of a germ cell mutation or germ cell mosaicism in the gonads of one of the parents, or a mutation in the fertilized egg itself. In one study, three of eight \"de novo\" mutations occurred in the postzygotic stage, leading to the estimate that up to one-third of \"de novo\" mutations result in somatic mosaicism. Not every mutation of the \"AR\" gene results in androgen insensitivity; one particular mutation occurs in 8 to 14% of genetic males, and is thought to adversely affect only a small number of individuals when other genetic factors are present.",
            "score": 272.5330286026001
        },
        {
            "docid": "18696706_3",
            "document": "Paroxysmal kinesigenic choreoathetosis . Paroxysmal kinesigenic dyskinesia has been shown to be inherited in an autosomal dominant fashion. In 2011, the PRRT2 gene on chromosome 16 was identified as the cause of the disease. The researchers looked at the genetics of eight families with strong histories of PKD. They employed whole genome sequencing, along with Sanger sequencing to identify the gene that was mutated in these families. The mutations in this gene included a nonsense mutation identified in the genome of one family and an insertion mutation identified in the genome of another family. The researchers then confirmed this gene as the cause of PKD when it was not mutated in the genome of 1000 control patients. Researchers found PRRT2 mutations in 10 of 29 sporadic cases affected with PKD, thus suggests PRRT2 is the gene mutated in a subset of PKD and PKD is genetically heterogeneous. The mechanism of how PRRT2 causes PKD still requires further investigation. However, researchers suggest it may have to do with PRRT2's expression in the basal ganglia, and the expression of an associated protein, SNAP25, in the basal ganglia as well. The pathophysiology of PKD is not fully explained. A few mechanisms have been suggested thus far: Multiple methods are being used to study the potential brain abnormalities of individuals with PKD compared with \u201cnormal\u201d individuals. These methods include SPECT studies, fMRI studies, and diffusion tensor imaging. The main problem with many of the studies concerned with the pathophysiology of the disorder is the small sample size. Because the studies normally only include about 7-10 patients with PKD, the results cannot be generalized to the entire population of patients. However, the studies do bring up possibilities for further study.",
            "score": 153.95766961574554
        },
        {
            "docid": "21647820_34",
            "document": "Whole genome sequencing . Whole genome sequencing has established the mutation frequency for whole human genomes. The mutation frequency in the whole genome between generations for humans (parent to child) is about 70 new mutations per generation. An even lower level of variation was found comparing whole genome sequencing in blood cells for a pair of monozygotic (identical twins) 100-year-old centenarians. Only 8 somatic differences were found, though somatic variation occurring in less than 20% of blood cells would be undetected.",
            "score": 137.67117714881897
        },
        {
            "docid": "2652481_8",
            "document": "Personalized medicine . In order for physicians to know if a mutation is connected to a certain disease, researchers often do a study called a \u201cgenome-wide association study\u201d (GWAS). A GWAS study will look at one disease, and then sequence the genome of many patients with that particular disease to look for shared mutations in the genome. Mutations that are determined to be related to a disease by a GWAS study can then be used to diagnose that disease in future patients, by looking at their genome sequence to find that same mutation. The first GWAS, conducted in 2005, studied patients with age-related macular degeneration (ARMD). It found two different mutations, each containing only a variation in only one nucleotide (called single nucleotide polymorphisms, or SNPs), which were associated with ARMD. GWAS studies like this have been very successful in identifying common genetic variations associated with diseases. As of early 2014, over 1,300 GWAS studies have been completed.",
            "score": 142.68181121349335
        },
        {
            "docid": "1530353_15",
            "document": "Mutation rate . The human mutation rate is higher in the male germ line (sperm) than the female (egg cells), but estimates of the exact rate have varied by an order of magnitude or more. This means that a human genome accumulates around 64 new mutations per generation because each full generation involves a number of cell divisions to generate gametes. Human mitochondrial DNA has been estimated to have mutation rates of ~3\u00d7 or ~2.7\u00d710 per base per 20 year generation (depending on the method of estimation); these rates are considered to be significantly higher than rates of human genomic mutation at ~2.5\u00d710 per base per generation. Using data available from whole genome sequencing, the human genome mutation rate is similarly estimated to be ~1.1\u00d710 per site per generation.",
            "score": 187.03713953495026
        },
        {
            "docid": "356200_4",
            "document": "Muller's ratchet . Asexual reproduction compels genomes to be inherited as indivisible blocks so that once the least mutated genomes in an asexual population begin to carry at least one deleterious mutation, no genomes with fewer such mutations can be expected to be found in future generations (except as a result of back mutation). This results in an eventual accumulation of mutations known as genetic load. In theory, the genetic load carried by asexual populations eventually becomes so great that the population goes extinct. In sexual populations, the process of genetic recombination allows the genomes of the progeny to be different from the genomes of the parents. In particular, progeny genomes with fewer mutations can be generated from more highly mutated parental genomes by putting together in progeny genomes mutation-free portions of parental chromosomes.",
            "score": 181.39922952651978
        },
        {
            "docid": "25_16",
            "document": "Autism . Studies of twins suggest that heritability is 0.7 for autism and as high as 0.9 for ASD, and siblings of those with autism are about 25 times more likely to be autistic than the general population. However, most of the mutations that increase autism risk have not been identified. Typically, autism cannot be traced to a Mendelian (single-gene) mutation or to a single chromosome abnormality, and none of the genetic syndromes associated with ASDs have been shown to selectively cause ASD. Numerous candidate genes have been located, with only small effects attributable to any particular gene. Most loci individually explain less than 1% of cases of autism. The large number of autistic individuals with unaffected family members may result from spontaneous structural variation\u00a0\u2014 such as deletions, duplications or inversions in genetic material during meiosis. Hence, a substantial fraction of autism cases may be traceable to genetic causes that are highly heritable but not inherited: that is, the mutation that causes the autism is not present in the parental genome.",
            "score": 173.40969920158386
        },
        {
            "docid": "3815307_13",
            "document": "James F. Crow . Crow also did research and writing in how DNA in sperm degrades as men age, through repeated copying, and can then be passed along to children in permanently degraded form, which they likely then pass on as well. As a result, he said in 1997 that the \"greatest mutational health hazard to the human genome is fertile older males\". He described mutations that have a direct visible effect on the child's health and also mutations that can be latent or have minor visible effects on the child's health; many such mutations allow the child to reproduce, but cause more serious problems for grandchildren, great-grandchildren and later generations However, evidence to support Crow's \"greatest mutational health hazard\" claim appears to be weak; a 2009 review concludes that the absolute risk from paternal age for genetic anomalies in offspring is low, and states that \"there is no clear association between adverse health outcome and paternal age but longitudinal studies are needed.\"",
            "score": 177.88415896892548
        },
        {
            "docid": "47824513_7",
            "document": "STAT3 GOF . These gain-of-function mutations have been identified as germline mutations, meaning variations in the lineage of germ cells. Most mutations identified were de novo, meaning originating in the symptomatic patient and not inherited from either parent. However, multiple cases of inheritance have also been identified. In 2 families, family members carrying a STAT3 mutation were asymptomatic or had a less severe phenotype, indicating that there are carriers of these mutations who display autosomal dominant inheritance with incomplete penetrance. Children of a parent who carries a STAT3 GOF mutation has a 50% chance of inheriting the mutation. Within a family, each child\u2019s risk of inheriting the mutated STAT3 gene is independent of whether other siblings have the mutation. In other words, if the first three children a family have the mutation, the fourth child has the same 50% risk of inheriting the mutation. Children who do not inherit the abnormal gene will not develop this syndrome or pass on the mutation.",
            "score": 242.5944366455078
        },
        {
            "docid": "2525541_15",
            "document": "Sandhoff disease . Sandhoff disease can be detected through the following procedures (before it is apparent through physical examination): a biopsy removing a sample of tissue from the liver, genetic testing, molecular analysis of cells and tissues (to determine the presence of a genetic metabolic disorder), enzyme assay, and occasionally a urinalysis to determine if the above-noted compounds are abnormally stored within the body. For a child to suffer from this disease, both parents must be carriers, and both must transmit the mutation to the child. Thus, even in the case where both parents have the mutation, there is only a 25 percent chance their child will inherit the condition. Frequently, parents are given the opportunity to have a DNA screening if they are at high risk, to determine their carrier status before they have children. However, it is also highly recommended to undergo testing even for those parents who do not have a family history of Sandhoff disease. Over 95% of the families that have children with Sandhoff disease had no known prior family history of the condition, as the mutation in the HEXB gene is \"silent,\" or recessive, and often passed undetected from one generation to the next Naturally, if an individual carries the mutation, he or she has a risk of transmitting it to the unborn child. Genetic counseling is recommended for those who have the mutation.",
            "score": 206.20693480968475
        },
        {
            "docid": "9028799_35",
            "document": "Bacteria . Bacteria, as asexual organisms, inherit an identical copy of the parent's genomes and are clonal. However, all bacteria can evolve by selection on changes to their genetic material DNA caused by genetic recombination or mutations. Mutations come from errors made during the replication of DNA or from exposure to mutagens. Mutation rates vary widely among different species of bacteria and even among different clones of a single species of bacteria. Genetic changes in bacterial genomes come from either random mutation during replication or \"stress-directed mutation\", where genes involved in a particular growth-limiting process have an increased mutation rate.",
            "score": 196.45281386375427
        },
        {
            "docid": "796412_2",
            "document": "Experimental evolution . Experimental evolution is the use of laboratory experiments or controlled field manipulations to explore evolutionary dynamics. Evolution may be observed in the laboratory as individuals/populations adapt to new environmental conditions by natural selection. There are two different ways in which adaptation can arise in experimental evolution. One is via an individual organism gaining a novel beneficial mutation. The other is from allele frequency change in standing genetic variation already present in a population of organisms. Other evolutionary forces outside of mutation and natural selection can also play a role or be incorporated into experimental evolution studies, such as genetic drift and gene flow. The organism used is decided by the experimenter, based off whether the hypothesis to be tested involves adaptation through mutation or allele frequency change. A large number of generations are required for adaptive mutation to occur, and experimental evolution via mutation is carried out in viruses or unicellular organisms with rapid generation times, such as bacteria and asexual clonal yeast. Polymorphic populations of asexual or sexual yeast, and multicellular eukaryotes like Drosophila, can adapt to new environments through allele frequency change in standing genetic variation. Organisms with longer generations times, although costly, can be used in experimental evolution. Laboratory studies with foxes and with rodents (see below) have shown that notable adaptations can occur within as few as 10\u201320 generations and experiments with wild guppies have observed adaptations within comparable numbers of generations. More recently, experimentally evolved individuals or populations are often analyzed using whole genome sequencing, an approach known as Evolve and Resequence (E&R). E&R can identify mutations that lead to adaptation in clonal individuals or identify alleles that changed in frequency in polymorphic populations, by comparing the sequences of individuals/populations before and after adaptation. The sequence data makes it possible to pinpoint the site in a DNA sequence that a mutation/allele frequency change occurred to bring about adaptation. The nature of the adaptation and functional follow up studies can shed insight into what effect the mutation/allele has on phenotype.",
            "score": 164.9177929162979
        },
        {
            "docid": "33890453_7",
            "document": "Genomics of domestication . However, looking solely at genes, or coding DNA, can be ineffective when examining certain traits or studying the evolution of a species during the domestication process. Genes that are vital for cellular process are often highly conserved and mutations at these locations can prove fatal. Areas of the genome that are noncoding can be prone to much higher mutation rates. Because of this, these noncoding genes provide vital information when studying the divergence of wild and domestic species. Since core genes are conserved between and among species, examining DNA sequences for these genes in multiple individuals of a species may be unable to provide much information on the diversity present in a population or species that is young. The estimated age of domesticated animal and plant species tends to be less than 10,000 years, which on an evolutionary timescale, is relatively short. Because of this, highly variable noncoding DNA, such as microsatellites, that mutate frequently, provide genetic markers with sufficient intraspecific variation to document domestication. Studying the noncoding DNA of domesticated species is made possible by genomics, which provides the genetic sequence of the entire genome, not simply coding DNA from genes of interest. In the case of coconuts, recent genomic research using 10 microsatellite loci was able to determine that there have been 2 cases of coconut domestication based on sufficient variation between individuals found in the Indian Ocean and those found in the Pacific Ocean.",
            "score": 137.58596789836884
        },
        {
            "docid": "346315_11",
            "document": "Human variability . Evolutionarily speaking, genetic mutations are the origins of differences in alleles between individuals. However, mutations may also occur within a person's life-time and be passed down from parent to offspring. In some cases, mutations may result in genetic diseases, such as Cystic Fibrosis, which is the result of a mutation to the CFTR gene that is recessively inherited from both parents. In other cases, mutations may be harmless or phenotypically unnoticeable. We are able to treat biological traits as manifestations of either a single loci or multiple loci, labeling said biological traits as either monogenic or polygenic, respectively. Concerning polygenic traits it may be essential to be mindful of inter-genetic interactions or epistasis. Although epistasis is a significant genetic source of biological variation, it is only additive interactions that are heritable as other epistatic interactions involve recondite inter-genetic relationships. Epistatic interactions in of themselves vary further with their dependency on the results of the mechanisms of recombination and crossing over.",
            "score": 181.6120001077652
        },
        {
            "docid": "45663583_2",
            "document": "Human interactome . The human interactome is the set of protein\u2013protein interactions (the interactome) that occur in human cells. The sequencing of reference genomes, in particular the Human Genome Project, has revolutionized human genetics, molecular biology, and clinical medicine. Genome-wide association study results have led to the association of genes with most Mendelian disorders, and over 140 000 germline mutations have been associated with at least one genetic disease. However, it became apparent that inherent to these studies is an emphasis on clinical outcome rather than a comprehensive understanding of human disease; indeed to date the most significant contributions of GWAS have been restricted to the \u201clow-hanging fruit\u201d of direct single mutation disorders, prompting a systems biology approach to genomic analysis. The connection between genotype and phenotype (how variation in genotype affects the disease or normal functioning of the cell and the human body) remain elusive, especially in the context of multigenic complex traits and cancer. To assign functional context to genotypic changes, much of recent research efforts have been devoted to the mapping of the networks formed by interactions of cellular and genetic components in humans, as well as how these networks are altered by genetic and somatic disease.",
            "score": 136.65615618228912
        },
        {
            "docid": "26062564_26",
            "document": "Cancer genome sequencing . A major goal of cancer genome sequencing is to identify driver mutations: genetic changes which increase the mutation rate in the cell, leading to more rapid tumor evolution and metastasis. It is difficult to determine driver mutations from DNA sequence alone; but drivers tend to be the most commonly shared mutations amongst tumors, cluster around known oncogenes, and are tend to be non-silent. Passenger mutations, which are not important in the progression of the disease, are randomly distributed throughout the genome. It has been estimated that the average tumor carries c.a. 80 somatic mutations, fewer than 15 of which are expected to be drivers.",
            "score": 163.01834774017334
        },
        {
            "docid": "1530353_3",
            "document": "Mutation rate . There are several natural units of time for each of these rates, with rates being characterized either as mutations per base pair per cell division, per gene per generation, or per genome per generation. The mutation rate of an organism is an evolved characteristic and is strongly influenced by the genetics of each organism, in addition to strong influence from the environment. The upper and lower limits to which mutation rates can evolve is the subject of ongoing investigation. However, the mutation rate does vary over the genome. Over DNA, RNA or a single gene, mutation rates are changing.",
            "score": 169.46357655525208
        },
        {
            "docid": "32706791_12",
            "document": "Genome instability . It is currently accepted that sporadic tumors (non-familial ones) are originated due to the accumulation of several genetic errors. An average cancer of the breast or colon can have about 60 to 70 protein altering mutations, of which about 3 or 4 may be \"driver\" mutations, and the remaining ones may be \"passenger\" mutations Any genetic or epigenetic lesion increasing the mutation rate will have as a consequence an increase in the acquisition of new mutations, increasing then the probability to develop a tumor. During the process of tumorogenesis, it is known that diploid cells acquire mutations in genes responsible for maintaining genome integrity (\"caretaker genes\"), as well as in genes that are directly controlling cellular proliferation (\"gatekeeper genes\"). Genetic instability can originate due to deficiencies in DNA repair, or due to loss or gain of chromosomes, or due to large scale chromosomal reorganizations. Losing genetic stability will favour tumor development, because it favours the generation of mutants that can be selected by the environment.",
            "score": 170.20622742176056
        },
        {
            "docid": "40977477_17",
            "document": "Cross-species transmission . Two methods of measuring genetic variation, variable number tandem repeats (VNTRs) and single nucleotide polymorphisms (SNPs), have been very beneficial to the study of bacterial transmission. VNTRs, due to the low cost and high mutation rates, make them particularly useful to detect genetic differences in recent outbreaks, and while SNPs have a lower mutation rate per locus than VNTRs, they deliver more stable and reliable genetic relationships between isolates. Both methods are used to construct phylogenies for genetic analysis, however, SNPs are more suitable for studies on phylogenies contraction. However, it can be difficult for these methods accurately simulate CSTs everts. Estimates of CST based on phylogenys made using VNTR marker can be biased towards detecting CST events across a wide range of the parameters. SNPs tend to be less biased and variable in estimates of CST when estimations of CST rates are low and low number of SNPs is used. In general, CST rate estimates using these methods are most reliable in systems with more mutations, more markers, and high genetic differences between introduced strains. CST is very complex and models need to account for a lot of parameters to accurately represent the phenomena. Models that oversimplify reality can result in biased data. Multiple parameters such as number of mutations accumulated since introduction, stochasticity, the genetic difference of strains introduced, and the sampling effort can make unbiased estimates of CST difficult even with whole-genome sequences, especially if sampling is limited, mutation rates are low, or if pathogens were recently introduced. More information on the factors that influence CST rates is needed for the contraction of more appropriate models to study these events.",
            "score": 153.66906476020813
        },
        {
            "docid": "45670352_15",
            "document": "Anzick-1 . Human nuclear DNA is located inside the nucleus of every cell and makes up the human genome. Humans inherit half of their nuclear DNA from their mother and half from their father. Throughout human evolution, mutations occur that are inherited in each subsequent generation. Different populations have different frequencies of these mutations, and population histories can be ascertained from these mutations by comparing the mutations of one individual to other genomes from specific ethnic groups.",
            "score": 157.44461178779602
        },
        {
            "docid": "186028_16",
            "document": "Regression toward the mean . Galton's explanation for the regression phenomenon he observed is now known to be incorrect. He stated: \u201cA child inherits partly from his parents, partly from his ancestors. Speaking generally, the further his genealogy goes back, the more numerous and varied will his ancestry become, until they cease to differ from any equally numerous sample taken at haphazard from the race at large.\u201d This is incorrect, since a child receives its genetic makeup exclusively from its parents. There is no generation-skipping in genetic material: any genetic material from earlier ancestors must have passed through the parents, but it may not have been \"expressed\" in them. The phenomenon is better understood if we assume that the inherited trait (e.g., height) is controlled by a large number of recessive genes. Exceptionally tall individuals must be homozygous for increased height mutations on a large proportion of these loci. But the loci which carry these mutations are not necessarily shared between two tall individuals, and if these individuals mate, their offspring will be on average homozygous for \"tall\" mutations on fewer loci than either of their parents. In addition, height is not entirely genetically determined, but also subject to environmental influences during development, which make offspring of exceptional parents even more likely to be closer to the average than their parents.",
            "score": 178.1989607810974
        },
        {
            "docid": "4071231_10",
            "document": "Causes of autism . CNV studies were closely followed by exome sequencing studies, which sequence the 1\u20132% of the genome that codes for proteins (the \"exome\"). These studies found that \"de novo\" gene inactivating mutations were observed in approximately 20% of individuals with autism, compared to 10% of unaffected siblings, suggesting the etiology of ASD is driven by these mutations in around 10% of cases. There are predicted to be 350-450 genes that significantly increase susceptibility to ASDs when impacted by inactivating \"de novo\" mutations. A further 12% of cases are predicted to be caused by protein altering missense mutations that change an amino acid but do not inactivate a gene. Therefore approximately 30% of individuals with autism have a spontaneous \"de novo\" large CNV that deletes or duplicates genes, or mutation that changes the amino acid code of an individual gene. A further 5\u201310% of cases have inherited structural variation at loci known to be associated with autism, and these known structural variants may arise \"de novo\" in the parents of affected children.",
            "score": 234.88785123825073
        },
        {
            "docid": "3232713_34",
            "document": "Heritability of autism . Clues to the first two questions come from studies that have shown that at least 30% of individuals with autism have spontaneous \"de novo\" mutations that occurred in the father's sperm or mother's egg and disrupt genes important for brain development, these spontaneous mutations likely cause autism in families where there is no family history. The concordance between identical twins isn't quite 100% for two reasons, because these mutations have variable 'expressivity' and their effects manifest differently due to chance effects, epigenetic, and environmental factors. Also spontaneous mutations can potentially occur specifically in one twin and not the other after conception. The likelihood of developing intellectual disability is dependent on the importance the effect the gene or mutation has on brain development, and also the genetic and environmental background upon which a mutation occurs. The recurrence of the same mutations in multiple individuals affected by autism has led Brandler and Sebat to suggest that the spectrum of autism is breaking up into quanta of many different genetic disorders.",
            "score": 233.32980597019196
        },
        {
            "docid": "49033_62",
            "document": "Epigenetics . Some human disorders are associated with genomic imprinting, a phenomenon in mammals where the father and mother contribute different epigenetic patterns for specific genomic loci in their germ cells. The best-known case of imprinting in human disorders is that of Angelman syndrome and Prader-Willi syndrome\u2014both can be produced by the same genetic mutation, chromosome 15q partial deletion, and the particular syndrome that will develop depends on whether the mutation is inherited from the child's mother or from their father. This is due to the presence of genomic imprinting in the region. Beckwith-Wiedemann syndrome is also associated with genomic imprinting, often caused by abnormalities in maternal genomic imprinting of a region on chromosome 11.",
            "score": 121.43787503242493
        },
        {
            "docid": "50780462_46",
            "document": "Evolution of the wolf . DNA studies are conducted but with \"the mutation rate as the dominant source of uncertainty.\" In 2005, Lindblad-Toh sequenced the first draft genome of the extant dog, and calculated a proposed mutation rate of 1x10 mutations per generation. In 2015, Skoglund was able to sequence the first draft genome of the 35,000 YBP Taimyr wolf and used its radio-carbon date to validate a proposed genetic mutation rate of 0.4x10 mutations per generation. The difference is a timing factor of 2.5, however another study stated that because only one Pleistocene wolf specimen has so far been sequenced, then the result should be treated with caution, with that study then providing both estimates to calculate the proposed divergence times between the wolf and dog. However, in 2016 the mutation rate of the 4,800 YBP Newgrange dog matched that of the Taimyr wolf.",
            "score": 144.80341029167175
        },
        {
            "docid": "21647820_36",
            "document": "Whole genome sequencing . In cancer, mutation frequencies are much higher, due to genome instability. This frequency can further depend on patient age, exposure to DNA damaging agents (such as UV-irradiation or components of tobacco smoke) and the activity/inactivity of DNA repair mechanisms. Furthermore, mutation frequency can vary between cancer types: in germline cells, mutation rates occur at approximately 0.023 mutations per megabase, but this number is much higher in breast cancer (1.18-1.66 somatic mutations per Mb), in lung cancer (17.7) or in melanomas (~33). Since the haploid human genome consists of approximately 3,200 megabases, this translates into about 74 mutations (mostly in noncoding regions) in germline DNA per generation, but 3,776-5,312 somatic mutations per haploid genome in breast cancer, 56,640 in lung cancer and 105,600 in melanomas.",
            "score": 156.67073678970337
        },
        {
            "docid": "46617123_6",
            "document": "Jan Vijg . Genome instability, i.e., the tendency of the genome to acquire mutations and epimutations, underlies human genetic disease, causally contributes to cancer and has also been implicated in aging and age-related, degenerative conditions other than cancer. Little is known about the mechanisms that give rise to spontaneous changes in the genome or epigenome and how this may lead, in somatic cells, to increased cancer risk and loss of organ and tissue function with age. We study genome and epigenome instability as a function of age in various model organisms, including mouse and fruit fly, and its consequences in terms of alterations in tissue-specific patterns of gene regulation. We developed transgenic reporter systems in mouse and fruit fly, which allow us to determine tissue-specific frequencies of various forms of genome instability, e.g., point mutations, deletions, translocations. By crossing the mutational reporter animals with mutants harboring specific defects in various genome maintenance pathways, the relevance of these pathways for the accumulation of specific forms of genome instability is assessed, in relation to the pathophysiology of aging. Similarly, by using knockdown approaches we assess the effect of specific genes implicated in longevity and healthy aging, e.g., SOD, FOXO, SIR2, on genome integrity. More recently, we have begun to assess global gene mutation and epimutation loads in normal and disease tissues of both animal models and humans using massively parallel sequencing approaches.",
            "score": 139.19853508472443
        },
        {
            "docid": "38057969_18",
            "document": "Progeroid syndromes . BS is caused by mutations in the BLM gene, which encodes for the Bloom syndrome protein, a RecQ helicase. These mutations may be frameshift, missense, non-sense, or mutations of other kinds and are likely to cause deletions in the gene product. Apart from helicase activity that is common to all RecQ helices, it also acts to prevent inappropriate homologous recombination. During replication of the genome, the two copies of DNA, called sister chromatids, are held together through a structure called the centromere. During this time, the homologous (corresponding) copies are in close physical proximity to each other, allowing them to 'cross' and exchange genetic information, a process called homologous recombination. Defective homologous recombination can cause mutation and genetic instability. Such defective recombination can introduce gaps and breaks within the genome and disrupt the function of genes, possibly causing growth retardation, aging and elevated risk of cancer. It introduces gaps and breaks within the genome and disrupts the function of genes, often causing retardation of growth, aging and elevated risks of cancers. The Bloom syndrome protein interacts with other proteins, such as topoisomerase III\u03b1 and RMI2, and suppresses illegitimate recombination events between sequences that are divergent from strict homology, thus maintaining genome stability. Individuals with BS have a loss-of-function mutation, which means that the illegitimate recombination is no longer suppressed, leading to higher rates of mutation (~10-100 times above normal, depending on cell type).",
            "score": 156.3343733549118
        },
        {
            "docid": "5630419_5",
            "document": "Preimplantation genetic haplotyping . PGH uses information regarding family history in conjunction with the use of linked polymorphic markers such as short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) to locate genes responsible for disease. Both STRs and SNPs are variations in gene nucleotides, and it is estimated that there are tens of millions of each type of variation in human DNA. High frequency of STRs or SNPs in alleles of affected individuals in comparison to their unaffected direct relatives indicates the origin of a disease causing mutation. They thus \"mark\" alleles as having a mutation without having to specifically identify the mutation. Because the number of potential STRs and SNPs is so high, a family pedigree helps to narrow the scope of alleles to analyze. Further, understanding how the gene of interest gets expressed over time helps ultimately determine which haplotype is responsible for the alleles linked to the mutation. A haplotype map is thus created, not only exhibiting genes the offspring will contain, but also the parental origin of the genes. Once the alleles that correlate with a mutation are characterized, PGH of the embryos is possible and only embryos carrying the low risk haplotypes are selected for transfer. PGH is performed in vitro until this point, when the chosen embryos get placed in the uterus of a surrogate mother for further development.",
            "score": 180.571391582489
        },
        {
            "docid": "54743_10",
            "document": "Inbreeding . Autosomal recessive disorders occur in individuals who have two copies of an allele for a particular recessive genetic mutation. Except in certain rare circumstances, such as new mutations or uniparental disomy, both parents of an individual with such a disorder will be carriers of the gene. These carriers do not display any signs of the mutation and may be unaware that they carry the mutated gene. Since relatives share a higher proportion of their genes than do unrelated people, it is more likely that related parents will both be carriers of the same recessive allele, and therefore their children are at a higher risk of inheriting an autosomal recessive genetic disorder. The extent to which the risk increases depends on the degree of genetic relationship between the parents; the risk is greater when the parents are close relatives and lower for relationships between more distant relatives, such as second cousins, though still greater than for the general population.",
            "score": 175.73351430892944
        }
    ],
    "r": [
        {
            "docid": "52789_9",
            "document": "Androgen insensitivity syndrome . As of 2010, over 400 \"AR\" mutations have been reported in the \"AR\" mutation database, and the number continues to grow. Inheritance is typically maternal and follows an X-linked recessive pattern; individuals with a 46,XY karyotype always express the mutant gene since they have only one X chromosome, whereas 46,XX carriers are minimally affected. About 30% of the time, the \"AR\" mutation is a spontaneous result, and is not inherited. Such \"de novo\" mutations are the result of a germ cell mutation or germ cell mosaicism in the gonads of one of the parents, or a mutation in the fertilized egg itself. In one study, three of eight \"de novo\" mutations occurred in the postzygotic stage, leading to the estimate that up to one-third of \"de novo\" mutations result in somatic mosaicism. Not every mutation of the \"AR\" gene results in androgen insensitivity; one particular mutation occurs in 8 to 14% of genetic males, and is thought to adversely affect only a small number of individuals when other genetic factors are present.",
            "score": 272.53302001953125
        },
        {
            "docid": "38898732_6",
            "document": "Alternating hemiplegia . The cause of alternating hemiplegia is the mutation of ATP1A3 gene. In a study of fifteen females and nine males\u2019 patient with alternating hemiplegia, a mutation in ATP1A3 gene was present. Three patients showed heterozygous de-novo missense mutation. Six patients were found with de-novo missense mutation and one patient was identified with de-novo splice site mutation. De novo mutation is a mutation that occurs in the germ cell of one parent. Neither parent has the mutation, but it is passed to the child through the sperm or egg.",
            "score": 266.5210266113281
        },
        {
            "docid": "41403879_5",
            "document": "Epilepsy syndromes . In general, genetics is believed to play an important role in epilepsies by a number of mechanisms. Simple and complex modes of inheritance have been identified for some of them. However, extensive screening has failed to identify many single rare gene variants of large effect. In the epileptic encephalopathies, de novo mutagenesis appear to be an important mechanism. De novo means that a child is affected, but the parents do not have the mutation. De novo mutations occur in eggs and sperms or at a very early stage of embryonic development. In Dravet syndrome a single affected gene was identified.",
            "score": 262.9137878417969
        },
        {
            "docid": "1150680_3",
            "document": "Germline mutation . Germline mutations can be caused by a variety of endogenous (internal) and exogenous (external) factors, and can occur throughout zygote development. A mutation that arises only in germ cells can result in offspring with a genetic condition that is not present in either parent; this is because the mutation is not present in the rest of the parents' body, only the germline. Due to many severe diseases stemming from \"de novo\" germline mutations, different gene editing techniques can be used to induce DNA breaks and repair the mutation.",
            "score": 260.5843200683594
        },
        {
            "docid": "1900228_15",
            "document": "Nemaline myopathy . The two most common gene mutations causing nemaline myopathy are found on \"NEB\" or \"ACTA1\". Mutations of the NEB gene usually result in symptoms present at birth or beginning in early childhood. This mutation results in about 50% of affected nemaline myopathy patients. The most common inheritance pathway for those with mutations in \"NEB\" is autosomal recessive in which each parent carries one mutated copy along with one normal functioning copy of the gene, and they pass the mutated copy to their offspring. In some cases, occasionally with \"ACTA1\" mutations, NM can be caused by an inheritance pattern of autosomal dominance. This mutation results in about 15 to 25 percent of the NM cases. The reason this is lower is because mutations resulting in the \"ACTA1\" gene would usually not be passed down from parents because this type of mutation happens spontaneously in the egg or sperm. When the condition is heritable, each pregnancy with the same partners has the same risk of passing the mutated genes to offspring. New mutations (de novo) can also occur causing NM and de novo mutations have been most often found to occur in the \"ACTA1\" gene. The risk of all cases of nemaline myopathy is the same in males and females.",
            "score": 259.90020751953125
        },
        {
            "docid": "4529789_6",
            "document": "X-linked severe combined immunodeficiency . X-SCID is caused by a mutation occurring in the xq13.1 locus of the X-chromosome. Most often, this disease affects males whose mother is a carrier (heterozygous) for the disorder. Because females have two X-chromosomes, the mother will not be affected by carrying only one abnormal X-chromosome, but any male children will have a 50% chance of being affected with the disorder by inheriting the faulty gene. Likewise, her female children will have a 50% chance of being carriers for the immunodeficiency. X-SCID can also arise through de novo mutations and can be prevented in females by X-inactivation. In X-inactivation the preferential selection of the non-mutant X chromosome during development results in the outcome that none of the mature female cells actively express the X-SCID mutation, they are immunologically unaffected and have no carrier burden. A de novo mutation is an alteration in a gene caused by the result of a mutation in a germ cell (egg or sperm) or in the fertilized egg itself, rather than having been inherited from a carrier. Since only 1/3 of all X-SCID patients have a positive family history of SCID, it is hypothesized that de novo mutations account for a significant percentage of cases. X-inactivation occurs in a completely random manner, in females, very early in embryonic development. Once an X is inactivated, it remains inactivated throughout the life of that cell and any of its daughter cells. It is important to note that X-inactivation is reversed in female germline cells, so that all new oocytes receive an active X. Regardless of which X is inactivated in her somatic cells, a female will have a 50% chance of passing on the disease to any male children.",
            "score": 252.479248046875
        },
        {
            "docid": "47824513_7",
            "document": "STAT3 GOF . These gain-of-function mutations have been identified as germline mutations, meaning variations in the lineage of germ cells. Most mutations identified were de novo, meaning originating in the symptomatic patient and not inherited from either parent. However, multiple cases of inheritance have also been identified. In 2 families, family members carrying a STAT3 mutation were asymptomatic or had a less severe phenotype, indicating that there are carriers of these mutations who display autosomal dominant inheritance with incomplete penetrance. Children of a parent who carries a STAT3 GOF mutation has a 50% chance of inheriting the mutation. Within a family, each child\u2019s risk of inheriting the mutated STAT3 gene is independent of whether other siblings have the mutation. In other words, if the first three children a family have the mutation, the fourth child has the same 50% risk of inheriting the mutation. Children who do not inherit the abnormal gene will not develop this syndrome or pass on the mutation.",
            "score": 242.5944366455078
        },
        {
            "docid": "23251776_13",
            "document": "Acquired characteristic . New mutations, (often somatic, spontaneous and sporadic), not inherited from either parent are called de novo mutations. The consensus on whether certain prenatal spontaneous mutations and genetic disorders that occur as a result of meiotic and chromosome errors or during cell division after conception, like Cystic fibrosis and Down syndrome, are considered to be acquired or inherited is unclear. Mutations and meiotic errors can be considered inherited since the organism is born with them \"in its genes\", but they can also be seen as prenatal acquired characteristics since they are \"not actually inherited\" from its parents. With de novo mutations and division errors, the relationship between the offspring's altered genes and gene inheritance from the parents is technically spurious. These genetic errors can affect the mind as well as the body and can result in schizophrenia, autism, bi-polar disorder , and cognitive disabilities.",
            "score": 240.22767639160156
        },
        {
            "docid": "4071231_10",
            "document": "Causes of autism . CNV studies were closely followed by exome sequencing studies, which sequence the 1\u20132% of the genome that codes for proteins (the \"exome\"). These studies found that \"de novo\" gene inactivating mutations were observed in approximately 20% of individuals with autism, compared to 10% of unaffected siblings, suggesting the etiology of ASD is driven by these mutations in around 10% of cases. There are predicted to be 350-450 genes that significantly increase susceptibility to ASDs when impacted by inactivating \"de novo\" mutations. A further 12% of cases are predicted to be caused by protein altering missense mutations that change an amino acid but do not inactivate a gene. Therefore approximately 30% of individuals with autism have a spontaneous \"de novo\" large CNV that deletes or duplicates genes, or mutation that changes the amino acid code of an individual gene. A further 5\u201310% of cases have inherited structural variation at loci known to be associated with autism, and these known structural variants may arise \"de novo\" in the parents of affected children.",
            "score": 234.88784790039062
        },
        {
            "docid": "3232713_34",
            "document": "Heritability of autism . Clues to the first two questions come from studies that have shown that at least 30% of individuals with autism have spontaneous \"de novo\" mutations that occurred in the father's sperm or mother's egg and disrupt genes important for brain development, these spontaneous mutations likely cause autism in families where there is no family history. The concordance between identical twins isn't quite 100% for two reasons, because these mutations have variable 'expressivity' and their effects manifest differently due to chance effects, epigenetic, and environmental factors. Also spontaneous mutations can potentially occur specifically in one twin and not the other after conception. The likelihood of developing intellectual disability is dependent on the importance the effect the gene or mutation has on brain development, and also the genetic and environmental background upon which a mutation occurs. The recurrence of the same mutations in multiple individuals affected by autism has led Brandler and Sebat to suggest that the spectrum of autism is breaking up into quanta of many different genetic disorders.",
            "score": 233.32980346679688
        },
        {
            "docid": "2223797_21",
            "document": "Saethre\u2013Chotzen syndrome . SCS is the most common craniosynostosis syndrome and affects 1 in every 25,000 to 50,000 individuals. It occurs in all racial and ethnic groups, and affects males and females equally. If a parent carries a copy of the SCS gene mutation, then there is a 50% chance their child will also carry a copy of the gene mutation, in which case, the child may or may not show signs of SCS. There is also a 50% chance their child will have two working copies of the gene, and would therefore, not have SCS. If both parents carry a single copy of the SCS gene mutation, then there is a 25% chance their child will have two gene mutation copies (so child would develop severe SCS), a 25% chance their child would have two normal copies of the gene (so would be completely normal), and a 50% chance their child would carry one gene mutation copy and 1 normal copy (so child may or may not display SCS). In rare situations, two normal parents can have a child with SCS due to a \"de novo\" mutation. The exact cause of the \"de novo\" mutation is unknown, but it doesn't seem to be related to anything that the parents did or didn't do during the pregnancy. SCS due to a \"de novo\" mutation is so rare that the proportion of past cases is unknown.",
            "score": 228.3406524658203
        },
        {
            "docid": "407000_6",
            "document": "Weissenbacher\u2013Zweym\u00fcller syndrome . Dominant genetic disorders can be caused by just a single copy of an abnormal gene. This abnormal gene can be the result of being inherited from either parent or be a new mutation. Most cases are caused by a de novo (new) mutation in the gene that occurs during the formation of the egg or sperm. These cases occur when there is no history of the disorder in the family. The COL11A2 gene is responsible for providing instructions on making one component of the type XI collagen. Type XI collagen is a complex molecule that helps give structure and strength to the connective tissues. Collagen is found in bone. It is also found in cartilage that makes up most of the skeleton during early development. The mutation of COL11A2 in Weissenbacher-Zweym\u00fcller syndrome disrupts the assembly of the type XI collagen molecules. The malfunctioning collagen weakens the connective tissue causing impaired bone development.  COL11A2 is also associated with autosomal dominant non-syndromic hearing loss (ADNSHL). All mutations of COL11A2 in ADNSHL are missense mutations.",
            "score": 227.5944061279297
        },
        {
            "docid": "1125767_15",
            "document": "Treacher Collins syndrome . TCS is inherited in an autosomal dominant manner and the penetrance of the affected gene is almost complete. Some recent investigations, though, described some rare cases in which the penetrance in TCS was not complete. Causes may be a variable expressivity, an incomplete penetrance or germline mosaicism. Only 40% of the mutations are inherited. The remaining 60% are a result of a \"de novo\" mutation, where a child has a new mutation in the responsible gene and did not inherit it from either parent. In the outcome of the disease, inter- and intrafamilial variability occurs. This suggests, when an affected child is born, it is important to investigate the parents to determine whether the affected gene is present, because the parent could have a mild form of the disease that has not been diagnosed. In this case, the risk of having another affected child is 50%. If the parents do not have the affected gene, the recurrence risk appears to be low. In following generations, the severity of the clinical symptoms increases.",
            "score": 226.3677215576172
        },
        {
            "docid": "19702_36",
            "document": "Mutation . The distinction between germline and somatic mutations is important in animals that have a dedicated germline to produce reproductive cells. However, it is of little value in understanding the effects of mutations in plants, which lack dedicated germline. The distinction is also blurred in those animals that reproduce asexually through mechanisms such as budding, because the cells that give rise to the daughter organisms also give rise to that organism's germline. A new germline mutation not inherited from either parent is called a \"de novo\" mutation.",
            "score": 225.467529296875
        },
        {
            "docid": "23294664_38",
            "document": "Dominant white . A mosaic mutation may or may not be inheritable, depending on the cell populations affected. Though this is not always the case, genetic mutations can occur spontaneously in one sex cell of a parent during gametogenesis. In these cases, called germline mutations, the mutation will be present in the single-celled zygote conceived from the affected sperm or egg cell, and the condition can be inherited by the next generation.",
            "score": 223.51239013671875
        },
        {
            "docid": "42008669_7",
            "document": "PASLI disease . PASLI disease is inherited in an autosomal dominant manner. This means one only needs a single abnormal gene from his/her parents to have PASLI disease. Of the two copies of \"PIK3CD\" each person carries, the abnormal \"PIK3CD\" gene dominates despite the fact that the matching \"PIK3CD\" gene from the other parent is normal. Additionally, dominant inheritance means most families with PASLI disease have affected relatives in each generation on the side of the family with the mutation. An alternative type of \"PIK3CD\" mutation is called \"de novo\", which means that the mutation was not inherited from the parents but rather spontaneously arose in the patient.",
            "score": 219.6480255126953
        },
        {
            "docid": "1150680_12",
            "document": "Germline mutation . Cystic Fibrosis is an autosomal recessive disorder that causes a variety of symptoms and complications, the most common of which is a thick mucus lining in lung epithelial tissue due to improper salt exchange, but can also affect the pancreas, intestines, liver, and kidneys. Many bodily processes can be affected due to the hereditary nature of this disease; if the disease is present in the DNA of both the sperm and the egg, then it will be present in essentially every cell and organ in the body; these mutations can occur initially in the germline cells, or be present in all parental cells. The most common mutation seen in this disease is \u0394F508, which means a deletion of the amino acid at the 508 position. If both parents have a mutated CFTR (cystic fibrosis transmembrane conductance regulator) protein, then their children have a 25% of inheriting the disease. If a child has 1 mutated copy of CFTR, they will not develop the disease, but will become a carrier of the disease.",
            "score": 217.7095184326172
        },
        {
            "docid": "18487326_5",
            "document": "Germline mosaicism . Germline mosaicism may contribute to the inheritance of many genetic conditions. Conditions that are inherited by means of germline mosaicism are often mistaken as being the result of de novo mutations. Various diseases are now being re-examined for presence of mutant alleles in the germline of the parents in order to further our understanding of how they can be passed on. The frequency of germline mosaicism is not known due to the sporadic nature of the mutations causing it and the difficulty in obtaining the gametes that must be tested to diagnose it.",
            "score": 215.5102081298828
        },
        {
            "docid": "7401690_3",
            "document": "Anophthalmia . The most genetic based cause for anophthalmia is caused by the SOX2 gene. Sox2 anophthalmia syndrome is caused by a mutation in the Sox2 gene that does not allow it to produce the Sox2 protein that regulates the activity of other genes by binding to certain regions of DNA. Without this Sox2 protein, the activity of genes that is important for the development of the eye is disrupted. Sox2 anophthalmia syndrome is an autosomal dominant inheritance, but the majority of patients who suffer from Sox2 anophthalmia are the first in their family history to have this mutation. In certain cases, one parent will possess the mutated gene only in their egg or sperm cell and the offspring will inherit it through that. This is called germline mosaicism. There are at least 33 mutations in the Sox2 gene that have been known to cause anophthalmia. Some of these gene mutations will cause the Sox2 protein not to be formed, while other mutations will yield a non-functional version of this protein.",
            "score": 215.0724334716797
        },
        {
            "docid": "4071231_7",
            "document": "Causes of autism . However, in spite of the strong heritability, most cases of ASD occur sporadically with no recent evidence of family history. It has been hypothesized that spontaneous \"de novo\" mutations in the father's sperm or mother's egg contribute to the likelihood of developing autism. There are two lines of evidence that support this hypothesis. First, individuals with autism have significantly reduced fecundity, they are 20 times less likely to have children than average, thus curtailing the persistence of mutations in ASD genes over multiple generations in a family. Second, the likelihood of having a child develop autism increases with advancing paternal age, and mutations in sperm gradually accumulate throughout a man's life.",
            "score": 211.28369140625
        },
        {
            "docid": "1106793_26",
            "document": "Familial adenomatous polyposis . NCBI states that \"Although most individuals diagnosed with an APC-associated polyposis condition have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.\" In addition around 20% of cases are a \"de novo\" mutation, and of those with an apparent de novo APC mutation (i.e. no known family history) 20% have somatic mosaicism. Asymptomatic individuals (and therefore asymptomatic family members) are also known to exist.",
            "score": 210.78472900390625
        },
        {
            "docid": "18487326_4",
            "document": "Germline mosaicism . Genetic mutations, including those that cause disease, can be carried in gamete cells and passed on to offspring even if the mutation is not present (expressed) in the parents' phenotype. Diseases caused by germline mosaicism can be difficult to diagnose as genetically-inherited because the mutant alleles are not likely to be present in the somatic cells. Somatic cells are more commonly used for genetic analysis because they are easier to obtain than gametes. If the disease is a result of pure germline mosaicism, then the disease causing mutant allele would never be present in the somatic cells. This is a source of uncertainty for genetic counselling. An individual may still be a carrier for a certain disease even if the disease causing mutant allele is not present in the cells that were analyzed because the causative mutation could still exist in some of the individual's gametes.",
            "score": 210.35360717773438
        },
        {
            "docid": "32768_10",
            "document": "Von Hippel\u2013Lindau disease . Genetic diagnosis is also useful in VHL disease diagnosis. In hereditary VHL, disease techniques such as southern blotting and gene sequencing can be used to analyse DNA and identify mutations. These tests can be used to screen family members of those afflicted with VHL disease; \"de novo\" cases that produce genetic mosaicism are more difficult to detect because mutations are not found in the white blood cells that are used for genetic analysis.",
            "score": 210.11032104492188
        },
        {
            "docid": "43741187_7",
            "document": "BENTA disease . This disorder is inherited in an autosomal dominant manner. \"Autosomal\" refers to the fact that every person has two CARD11 alleles, one inherited from each parent. This is in contrast to sex-linked chromosomes. \"Dominant\" means that the abnormal allele dominates the matching, normal allele. Only one of the two copies (alleles) of CARD11 needs to be abnormal for a person to have BENTA disease. BENTA disease can also arise spontaneously in a patient as the result of a \"de novo\" mutations in CARD11, which means that the mutation was not inherited from the parents. In this case the patient could still pass on the mutation to his/her children.",
            "score": 209.9088134765625
        },
        {
            "docid": "30655078_3",
            "document": "Hand-foot-genital syndrome . Hand-foot-genital syndrome is inherited in an autosomal dominant manner. The proportion of cases caused by de novo mutations is unknown because of the small number of individuals described. If a parent of the proband is affected, the risk to the siblings is 50%. When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low. Each child of an individual with HFGS has a 50% chance of inheriting the mutation. Prenatal testing may be available through laboratories offering custom prenatal testing for families in which the disease-causing mutation has been identified in an affected family member.",
            "score": 209.73997497558594
        },
        {
            "docid": "29214038_4",
            "document": "Perlman syndrome . The gene thought to cause some of the cases of Perlman syndrome is DIS3L2 found on chromosome 2 at 2q37.2 and is thought to have an important role in the mitotic cell cycle. Although both sexes are affected, the sex ratio of male to female is 2:1. The syndrome has been described in both consanguineous and non-consanguineous couplings. No chromosomal abnormalities have been observed, except for in the case of Chernos et al., which showed a \"de novo\" mutation \u2014 an extra G positive band, a genetic mutation that neither parent possessed nor transmitted \u2014 on the tip of the short arm of chromosome 11.",
            "score": 208.81045532226562
        },
        {
            "docid": "8444537_5",
            "document": "Neuropathy, ataxia, and retinitis pigmentosa . This condition is inherited in a pattern reflecting its location in mitochondrial DNA, which is also known as maternal inheritance. This pattern of inheritance applies to genes contained in mitochondrial DNA. Because egg cells, but not sperm cells, contribute mitochondria to the developing embryo, only females pass mitochondrial conditions to their children. Mitochondrial disorders can appear in every generation of a family and can affect both males and females, but fathers do not pass mitochondrial traits to their children. Most of the body's cells contain thousands of mitochondria, each with one or more copies of mitochondrial DNA. The severity of some mitochondrial disorders is associated with the percentage of mitochondria in each cell that has a particular genetic change. Most individuals with NARP have a specific MT-ATP6 mutation in 70 percent to 90 percent of their mitochondria. When this mutation is present in a higher percentage of a person's mitochondria\u2014greater than 90 percent to 95 percent\u2014it causes a more severe condition known as maternally inherited Leigh syndrome. Because these two conditions result from the same genetic changes and can occur in different members of a single family, researchers believe that they may represent a spectrum of overlapping features instead of two distinct syndromes.",
            "score": 208.75479125976562
        },
        {
            "docid": "910135_4",
            "document": "Alexander disease . Alexander disease is a genetic disorder affecting the midbrain and cerebellum of the central nervous system. It is caused by mutations in the gene for glial fibrillary acidic protein (GFAP) that maps to chromosome 17q21. It is inherited in an autosomal dominant manner, such that the child of a parent with the disease has a 50% chance of inheriting the condition, if the parent is heterozygotic. However, most cases arise \"de novo\" as the result of sporadic mutations.",
            "score": 208.194580078125
        },
        {
            "docid": "52265475_4",
            "document": "LMNA-related congenital muscular dystrophy . It is an autosomal dominant inherited disease that affects both male and female. It is dominantly inherited because the abnormal gene would dominate beyond the normal one and it would transmit the disease. But it can also be recessive inheritance, which means that parents would carry the disease but it would not appear.Moreover, this disease is also caused by de novo mutations, which are spontaneous mutations. Therefore, although parents have normal genes, children who are affected by mutations will have kids that would suffer the same disease as it is transmitted through heredity.This dystrophy was discovered thanks to geneticist, Gis\u00e8le Bonne, who identified the first mutation of the LMNA gene in 1999.",
            "score": 207.592529296875
        },
        {
            "docid": "799960_10",
            "document": "Kabuki syndrome . Kabuki syndrome is one of the mendelian disorders of epigenetic machinery. Most cases of Kabuki syndrome occur \"de novo\", that is, the parents are unaffected and the gene was mutated early in embryological development. It is classified as a Mendelian disorder because individuals who have a de novo mutation in a specific gene pass the mutation to offspring according to the laws of Mendelian inheritance. There are two known genes that cause Kabuki syndrome: \"KMT2D\" and \"KDM6A\". However, about 30% of cases have no identifiable causative mutation.",
            "score": 207.57632446289062
        },
        {
            "docid": "5020632_4",
            "document": "Freeman\u2013Sheldon syndrome . FSS is caused by genetic changes. Krakowiak et al. (1998) mapped the distal arthrogryposis multiplex congenita (DA2B; MIM #601680) gene, a syndrome very similar in phenotypic expression to classic FSS, to 11p15.5-pter. Other mutations have been found as well. In FSS, inheritance may be either autosomal dominant, most often demonstrated. or autosomal recessive (MIM 277720). Alves and Azevedo (1977) note most reported cases of DA2A have been identified as new allelic variation. Toydemir et al. (2006) showed that mutations in embryonic myosin heavy chain 3 (MYH3; MIM *160270), at 17p-13.1-pter, caused classic FSS phenotype, in their screening of 28 (21 sporadic and 7 familial) probands with distal arthrogryposis type 2A. In 20 patients (12 and 8 probands, respectively), missense mutations (R672H; MIM *160270.0001 and R672C; MIM *160270.0002) caused substitution of arg672, an embryonic myosin residue retained post-embryonically. Of the remaining 6 patients in whom they found mutations, 3 had missense private de novo (E498G; MIM *160270.0006 and Y583S) or familial mutations (V825D; MIM *160270.0004); 3 other patients with sporadic expression had de novo mutations (T178I; MIM *160270.0003), which was also found in DA2B; 2 patients had no recognized mutations.",
            "score": 206.2953643798828
        },
        {
            "docid": "2525541_15",
            "document": "Sandhoff disease . Sandhoff disease can be detected through the following procedures (before it is apparent through physical examination): a biopsy removing a sample of tissue from the liver, genetic testing, molecular analysis of cells and tissues (to determine the presence of a genetic metabolic disorder), enzyme assay, and occasionally a urinalysis to determine if the above-noted compounds are abnormally stored within the body. For a child to suffer from this disease, both parents must be carriers, and both must transmit the mutation to the child. Thus, even in the case where both parents have the mutation, there is only a 25 percent chance their child will inherit the condition. Frequently, parents are given the opportunity to have a DNA screening if they are at high risk, to determine their carrier status before they have children. However, it is also highly recommended to undergo testing even for those parents who do not have a family history of Sandhoff disease. Over 95% of the families that have children with Sandhoff disease had no known prior family history of the condition, as the mutation in the HEXB gene is \"silent,\" or recessive, and often passed undetected from one generation to the next Naturally, if an individual carries the mutation, he or she has a risk of transmitting it to the unborn child. Genetic counseling is recommended for those who have the mutation.",
            "score": 206.20692443847656
        }
    ]
}